Elanco Animal Health Incorporated
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ELAN research report →
Companywww.elanco.com
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations.
- CEO
- Jeffrey N. Simmons
- IPO
- 2018
- Employees
- 9,000
- HQ
- Greenfield, IN, US
Price Chart
Valuation
- Market Cap
- $10.44B
- P/E
- -42.99
- P/S
- 2.13
- P/B
- 1.60
- EV/EBITDA
- 18.55
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 49.44%
- Op Margin
- 8.95%
- Net Margin
- -4.95%
- ROE
- -3.64%
- ROIC
- 3.77%
Growth & Income
- Revenue
- $4.71B · 6.22%
- Net Income
- $-232,000,000 · -168.64%
- EPS
- $-0.47 · -169.12%
- Op Income
- $252.00M
- FCF YoY
- -27.92%
Performance & Tape
- 52W High
- $27.72
- 52W Low
- $12.40
- 50D MA
- $23.11
- 200D MA
- $21.95
- Beta
- 1.69
- Avg Volume
- 5.71M
Get TickerSpark's AI analysis on ELAN
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 15, 26 | Modi Rajeev A. | buy | 4,911 |
| May 15, 26 | Modi Rajeev A. | other | 74.367 |
| May 15, 26 | Simmons Jeffrey N | buy | 4,971 |
| May 15, 26 | Simmons Jeffrey N | other | 142.343 |
| May 15, 26 | VanHimbergen Robert M | other | 9.92 |
| May 1, 26 | Modi Rajeev A. | other | 65.612 |
| May 1, 26 | Simmons Jeffrey N | other | 125.586 |
| May 1, 26 | VanHimbergen Robert M | other | 8.753 |
| Apr 17, 26 | Simmons Jeffrey N | other | 119.381 |
| Apr 17, 26 | VanHimbergen Robert M | other | 8.32 |
Our ELAN Coverage
We haven't published any research on ELAN yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate ELAN Report →